The Asia Pacific GMP cytokines market is expected to reach US$ 33.37 million by 2027 from US$ 17.27 million in 2019; it is estimated to grow at a CAGR of 8.6% from 2020 to 2027.
The growth of the Asia Pacific GMP cytokines market is attributed to key driving factors, such as increase in acceptance of cytokines for cancer and autoimmune therapies and potential contribution in stem cell therapy. However, high cost associated with GMP cytokines market therapy is expected to obstruct the growth of the market to a certain extent during the forecast period.
Cytokines play a significant role in regulating innate and adaptive immunity, which enables cells of the immune system to communicate over short distances. The cytokines therapy to activate cancer patients' immune systems has been an essential parameter in the treatment. Several research activities have proved cytokines' ability to limit tumor cell growth by a direct anti-proliferative or pro-apoptotic activity. Moreover, some cytokines indirectly inhibit tumor growth by stimulating the cytotoxic activity of immune cells against tumor cells. Similarly, rising prevalence of autoimmune disorders is expected to impact the adoption of cytokines-based therapeutics positively. As per data revealed by the Australian Institute of Health and Welfare (AIHW), on August 25, 2020, about 456,000 Australians (1.9% of the total population) suffer from rheumatoid arthritis. This effectiveness of cytokines therapies over cancer and autoimmune disorders, coupled with increasing prevalence of the disease, is likely to drive the market by 2027. Additionally, increasing number of investments and collaborations by market players to develop cytokines therapies over chronic disorders are also expected to accelerate the market growth.
Asia Pacific has been witnessing a growing number of COVID-19 cases since its outbreak. Cytokines play a significant role in the immune reaction to coronavirus infection. Some of the market players are also focusing on developing cytokine-based therapies to deal with COVID-19 pandemic. This factor is expected to positively impact the Asia Pacific GMP cytokines market during the forecast period.
Asia Pacific GMP Cytokines Market Revenue and Forecast to 2027 (US$ Mn)
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Asia Pacific GMP Cytokines MarketSegmentation
ByType
- TNF
- Interleukin
- Growth Factor
- Others
By Application
- Cell and Gene Therapy
- Tissue-Engineered Products
- Others
By Country
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
Company Profiles
- Miltenyi Biotec
- Sino Biological Inc.
- ABCAM
- PeproTech, Inc.
- Akron Biotech
- BIO-TECHNE CORPORATION
- CREATIVE BIOARRAY
- Proteintech Group, Inc.
- REPROCELL, Inc.
Asia Pacific GMP Cytokines Report Scope
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 17.27 Million |
Market Size by 2027 | US$ 33.37 Million |
Global CAGR (2020 - 2027) | 8.6% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By Type
|
Regions and Countries Covered | Asia-Pacific
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials
Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.















- Miltenyi Biotec
- Sino Biological Inc.
- ABCAM
- PeproTech, Inc.
- Akron Biotech
- BIO-TECHNE CORPORATION
- CREATIVE BIOARRAY
- Proteintech Group, Inc.
- REPROCELL, Inc.


